NCHC ACTION FUND for NCHC ACTION FUND
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to transparency and competition in the prescription drug market; the FDA Appropriations Act; S. 3056, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016; S. 3335 Fair Accountability and Innovative Research Drug Pricing (FAIR)Act of 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN ROTHER | — |
Medicare/Medicaid MMM
Issues related to transparency and competition in the prescription drug market
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN ROTHER | — |
Pharmacy PHA
Issues related to transparency and competition in the prescription drug market; the FDA Appropriations Act; S. 3056, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016; S. 3335 Fair Accountability and Innovative Research Drug Pricing (FAIR)Act of 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN ROTHER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.